Autoimmune disease etiology-a perplexing paradox or a turning leaf?

Autoimmunity Reviews

Volumn 6, Issue 4, 2007, Pages 204-208

  Williams Jr , Ralph C ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Autoantibodies; Autospecificity; Harmful messenger molecules

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; HLA ANTIGEN; SIGNAL PEPTIDE;

ANTIBODY STRUCTURE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CLINICAL FEATURE; DOWN REGULATION; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INFLAMMATION; REVIEW; RHEUMATOID ARTHRITIS; SCLERODERMA; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE INJURY;

ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS;

EID: 33847015533     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2006.08.012     Document Type: Review

References (25)

1. Munthe E., and Natvig J.B. Immunoglobulin classes, subclasses and complexes of IgG rheumatoid factor in rheumatoid plasma cells. Clin Exp Immunol 12 (1972) 55-70
2. Nowoslawski A., and Brzosko W.J. Immunopathology of rheumatoid arthritis I. The rheumatoid synovitis. Pathol Eur 2 (1967) 198-219
3. Smiley J.D., Sachs C., and Ziff M. In vitro synthesis of immunoglobulins by rheumatoid synovial membrane. J Clin Invest 47 (1968) 624-632
4. Waaler E. On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles. Acta Pathol Microbiol Scand 17 (1940) 172-188
5. Singer J.M., and Plotz C.M. The latex fixation test. I Application to the serologic diagnosis of rheumatoid arthritis. Am J Med 21 (1956) 888-892
6. Franklin E.C., Holman H.R., Müller-Eberhard H.J., et al. An unusual protein component of high molecular weight in the serum of certain patients with rheumatoid arthritis. J Exp Med 105 (1957) 425-438
7. Edelman G.M., Kunkel H.G., and Franklin E.C. Interaction of rheumatoid factor with antigen-antibody complexes and aggregated gamma globulin. J Exp Med 108 (1958) 105-120
8. Mongan E.S., Cass R.M., Jacox R.F., et al. A study of the relation of seronegative and seropositive rheumatoid arthritis to each other and to necrotizing vasculitis. Am J Med 47 (1969) 23-35
9. Williams Jr. R.C., and Kunkel H.G. Rheumatoid factor, complement and conglutinin aberations in patients with subacute bacterial endocarditis. J Clin Invest 41 (1962) 666-675
10. Harboe H., Rau B., and Aho K. Properties of various anti-globulin factors in human sera. J Exp Med 121 (1965) 503-519
11. Fudenberg H.H., and Kunkel H.G. Specificity of the reaction between rheumatoid factors and gamma globulin. J Exp Med 114 (1961) 257-278
12. Grubb R., Kronvall G., and Martensson L. Some aspects of the relations between rheumatoid arthritis, anti-gamma-globulin factors and the polymorphism of human gamma globulin. Ann N Y Acad Sci 124 (1965) 865-872
13. Williams Jr. R.C., Malone C.C., and Casali P. Antibody-induced aggregation of Gm(a)(-) Gm(g)(-) IgG results in exposure of determinants recognized by heteroclitic polyclonal and monoclonal anti-Gm(a) and Gm(g) human rheumatoid factors. Relevance to the in vivo induction of high affinity anti-IgG autoantibodies. J Immunol 149 (1992) 1817-1824
14. Williams Jr. R.C., Malone C.C., and Solomon A. Conformational dependency of human IgG heavy chain-associated Gm allotypes. Mol Immunol 30 (1993) 341-351
15. Aho K., Palosuo T., Heliovaara M., Knekt P., et al. Anti-filaggrin antibodies within "normal" range predict rheumatoid arthritis in a linear fashion. J Rheumatol 27 (2000) 2743-2746
16. Rantapaa-Dahlquist S., de Jong B.A., Berglin E., et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48 (2003) 2741-2749
17. Nielen M.M., van Schaardenburg D., Reesink H.W., et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50 (2004) 380-386
18. Koffler D., Schur P., and Kunkel H.G. Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med 126 (1967) 607
19. Tan E.M., and Kunkel H.G. An immunofluorescent study of the skin lesions in systemic lupus erythematosus. Arthritis Rheum 9 (1966) 37
20. Williams Jr. R.C., and Law IV D.H. Serum complement in connective tissue disorders. J Lab Clin Med 52 (1958) 273
21. Estes D., and Christian C.L. The natural history of systemic lupus erythematosus by prospective analysis. Medicine 50 (1971) 85
22. Maloney D.G., Grillo-Lopez A.J., White C.A., et al. IDEC-C2B8 (Rituximab) anti-CD 20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkins. Lymphoma Blood 90 (1997) 2188
23. Multani P., and White C.A. Rituximab. Cancer Chemother Biol Response Modif 21 (2003) 235
24. Leandro M.D., Edwards J.C., Cambridge G., et al. An open study of B lymphocyte depletion in systemic lupus erythematosus. Arthritis Rheum 46 (2002) 2673-2677
25. Edwards J.CW., and Cambridge G. Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology 40 (2001) 205-211